InvestorsHub Logo
Followers 1
Posts 972
Boards Moderated 0
Alias Born 02/14/2018

Re: DewDiligence post# 88173

Tuesday, 12/18/2018 2:05:46 PM

Tuesday, December 18, 2018 2:05:46 PM

Post# of 108192
Do you believe this cost issue would translate similarly to other NEO antigen companies, or is this something particular to the process in which Advaxis/Amgen have decided to design the drug? Or maybe we just don't have enough info? Thanks.

We all know how expensive CAR-T is. I'm amazed the cost is so prohibitive for Amgen that they wanted to terminate the agreement before seeing any results.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News